Tumor antigen-specific CD4+ T effector cells play a crucial role in maintaining anti-tumoral immune responses, producing important cytolytic granule molecules like Gzm and perforin; CD8+ T cells direct toxicity, contributing to protective and pathogenic immunity. The gene discussed is PRF1; the disease is neoplasm.